Ensuring that injectable bicarbonate-buffered lidocaine-epinephrine complies with 2015 United States Pharmacopeia (USP) compounding provisions

Prescilia Isedeh; M Laird Forrest; Deede Liu; Daniel Aires

doi:10.1016/j.jaad.2016.03.051

Ensuring that injectable bicarbonate-buffered lidocaine-epinephrine complies with 2015 United States Pharmacopeia (USP) compounding provisions

J Am Acad Dermatol. 2016 Aug;75(2):454-5. doi: 10.1016/j.jaad.2016.03.051.

Authors

Prescilia Isedeh¹, M Laird Forrest², Deede Liu¹, Daniel Aires³

Affiliations

¹ Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas.
² Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas.
³ Division of Dermatology, University of Kansas Medical Center, Kansas City, Kansas. Electronic address: [email protected].

No abstract available

Keywords: International Organization for Standardization class; United States Pharmacopeia; bicarbonate-buffered lidocaine-epinephrine; compounded sterile preparations; microbial risk.

Publication types

Editorial

MeSH terms

Anesthetics, Local / chemistry*
Bicarbonates
Buffers
Drug Compounding / standards*
Drug Contamination
Epinephrine / chemistry*
Lidocaine / chemistry*

Substances

Anesthetics, Local
Bicarbonates
Buffers
Lidocaine
Epinephrine

Publication types

MeSH terms

Substances

Grants and funding